Cargando…
A wide spectrum of clinical and brain MRI findings in patients with SLC19A3 mutations
BACKGROUND: SLC19A3 (solute carrier family 19, member 3) is a thiamin transporter with 12 transmembrane domains. Homozygous or compound heterozygous mutations in SLC19A3 cause two distinct clinical phenotypes, biotin-responsive basal ganglia disease and Wernicke's-like encephalopathy. Biotin an...
Autores principales: | Yamada, Kenichiro, Miura, Kiyokuni, Hara, Kenju, Suzuki, Motomasa, Nakanishi, Keiko, Kumagai, Toshiyuki, Ishihara, Naoko, Yamada, Yasukazu, Kuwano, Ryozo, Tsuji, Shoji, Wakamatsu, Nobuaki |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022826/ https://www.ncbi.nlm.nih.gov/pubmed/21176162 http://dx.doi.org/10.1186/1471-2350-11-171 |
Ejemplares similares
-
High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice
por: Suzuki, Kaoru, et al.
Publicado: (2017) -
Clinical and biochemical characterization of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency that causes Leigh-like disease and ketoacidosis
por: Yamada, Kenichiro, et al.
Publicado: (2014) -
The effect of rapamycin, NVP-BEZ235, aspirin, and metformin on PI3K/AKT/mTOR signaling pathway of PIK3CA-related overgrowth spectrum (PROS)
por: Suzuki, Yasuyo, et al.
Publicado: (2017) -
Reading impairment after neonatal hypoglycemia with parieto-temporo-occipital injury without cortical blindness: A case report
por: Kurahashi, Naoko, et al.
Publicado: (2023) -
Prevalence and modifiable risk factors for dementia in persons with intellectual disabilities
por: Takenoshita, Shintaro, et al.
Publicado: (2023)